By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > What Clinicians Must Know About Paracetamol Poisoning: Beyond Acute Liver Injury

What Clinicians Must Know About Paracetamol Poisoning: Beyond Acute Liver Injury

GMJ
Last updated: 01/07/2026 21:04
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Medical chart showing paracetamol poisoning statistics and outcomes data
A 15-year Australian study of 12,047 paracetamol poisoning cases reveals that while severe liver injury is rare (4.7%), nearly a quarter of patients experience repeat poisoning attempts within five years. The research highlights critical gaps in post-overdose mental health care and long-term mortality risks. — Photo: www.kaboompics.com / Pexels
SHARE
1 min read|134 words

The largest long-term study of paracetamol poisoning outcomes offers four critical clinical insights. First, 85% of cases are intentional overdoses, predominantly affecting young women aged 15-24 years, indicating a mental health crisis rather than accidental poisoning. Second, nearly one in four patients attempt repeat poisoning within five years, demonstrating the chronic nature of underlying self-harm behaviors.

Third, mortality risk remains elevated for the full 15-year follow-up period, even when acute liver injury is averted. Fourth, current hospital discharge protocols focus on toxicological management and miss opportunities for psychiatric intervention.

These findings have immediate clinical implications: paracetamol poisoning admissions require mandatory mental health assessment, crisis counseling before discharge, and coordinated long-term psychiatric care. Hospitals must recognize that preventing severe liver injury represents only partial success; preventing repeat attempts and long-term mortality demands integrated mental health services.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Paracetamol Poisoning Study Reveals High Risk of Repeated Attempts and Long-term Mortality →

Related reference
  • Paracetamol · Drug
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Corrected Global Data on Substance Use Burden Across 204 Countries Reveals Shifting Patterns

Nature Medicine has published a corrected Global Burden of Disease assessment of…

Engineered Heart Muscle From Stem Cells Shows Promise in First-in-Human Trial

A first-in-human clinical trial of engineered heart muscle derived from induced pluripotent…

Most People Who Stop GLP-1 Drugs Like Ozempic Eventually Return to Treatment

A new analysis of treatment patterns shows that many patients who discontinue…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

CLUSTER ALERT: Cross-Border Ebola Outbreak – DRC/Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Microscopic image of microglia brain immune cells responding to amyloid and tau proteins

New Study Identifies Brain’s Immune Gatekeepers in Dementia Resistance

By
Prof. Giorgi Pkhakadze
19/06/2026
Dexcom G7 continuous glucose monitoring sensor with FDA safety alert overlay

What Patients Should Know About the Dexcom G7 Sensor Theft

By
Prof. Giorgi Pkhakadze
07/07/2026

EBOLA OUTBREAK – DRC/UGANDA CROSS-BORDER TRANSMISSION – PHEIC DECLARED

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up